#glioblastoma

“We have reason to hope that the basic principle could help glioblastoma patients. The next step is to work on a clinical trial to test it.”

The problem with this attitude is that if anything goes—if everything is permissible—then nothing matters.

A Phase II trial tested SurVaxM in combination with standard therapy for the aggressive brain cancer.

For this year’s annual gala, Make the Magic 2019, I was invited to share our family’s story. Thank you, CK at BSU, for your love and care.

The vaccine, based on an individual’s own tumor cells, improved survival time and proved safe in an early-stage trial.

Join us Sunday, April 28, 2019, to raise money, awareness, and connectedness with and for the National Brain Tumor Society!

A new breed of patient advocate is reshaping the future of cancer research.

Adam Hayden is a 36-year-old philosopher, advocate and writer who lives in Indianapolis with his wife and three sons.

I recognize that I feel powerless. Without claiming too much, I imagine my spouse to feel powerless, too.

“More of these studies are needed to make progress in…precision, or personalized, medicine,” said NCI’s Konstantin Salnikow, PhD.

During treatments, Tim Reagan says it was hard to get up each day to walk his dog, Brady. But getting up and out was exactly what he needed.

I’ve raised before the issue of talking to kids about cancer, but we face a combination of factors that affects our kids in untold ways.

Financial toxicity is also about the systemic designs of our assistance programs, which are not equipped to meet the needs of the very ill.

New target identified in glioblastoma could be effective against a common immortality mechanism in one third of cancers.

We are a community; how might we all learn together from our shared yet unique experiences?

Clinical trial tests personalized treatments in push to improve pediatric cancer survival.